The Korean Journal of Urological Oncology 2015;13(2):43-50.
Published online August 30, 2015.
림프절 전이 방광암에서 림프절 관련 인자들의 예후 가치
유상준, 정인갑
울산대학교 의과대학 비뇨기과학교실, 서울아산병원 비뇨기과
Lymph Node-related Parameters as Prognostic Markers in Lymph Node Positive Bladder Cancer
Sangjun Yoo , In Gab Jeong
Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Correspondence:  In Gab Jeong
In spite of multidisciplinary treatment, about 70% of lymph node(LN) positive bladder cancer reported to be recurred within 5-year after radical cystectomy and pelvic lymphadenectomy although considerable number of patients survived for a long period without adjuvant treatment after surgery. Current TNM nodal staging system doesn’t account for this survival differences. In this regard, several LN-related parameters were developed to predict prognosis of LN positive bladder cancer. In this article, we will state the controversies on current TNM nodal staging system for bladder cancer. In addition, we will review the accuracy of imaging studies to predict LN metastasis before surgery and impact of several surgical and pathologic LN-related parameters, such as extent of lymphadenectomy, number of removed LNs, number of metastatic LNs, LN density, extracapsular extension of LN, on prognosis of LN positive bladder cancer. Moreover, we will review the value of adjuvant chemotherapy on LN positive bladder cancer. (Korean J Urol Oncol 2015;13:43-50)
Key Words: Urinary bladder neoplasm, Lymph nodes, Lymph node excision, Cystectomy, Chemotherapy, Adjuvant

Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email:
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail:

Copyright © The Korean Urological Oncology Society.

Developed in M2PI